CS Diagnostics Corp. (CSDX)
OTCMKTS
· Delayed Price · Currency is USD
0.0700
+0.0216 (44.63%)
Jun 26, 2025, 4:00 PM EDT
CS Diagnostics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
9.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
CS Diagnostics News
- 3 days ago - CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th - GlobeNewsWire
- 9 days ago - CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT - Accesswire
- 2 months ago - CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS - Accesswire
- 3 months ago - OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval - Accesswire
- 5 months ago - CS Diagnostics Corp. Announces U.S. Launch of MEDUSA - Business Wire